Latest / Pharmacy Podcast Network / Data-Driven & Dial In: Mastering Targeted Marketing | Marketing Vitals
Transcript
- 0:07Speaker 1: Thanks for listening to the Pharmacy Podcast Network.
- 0:23Speaker 2: As your business is marketing flatlined, find your pulse again
- 0:28Speaker 2: with Marketing Vitals bringing you innovative, intern key healthcare marketing
- 0:33Speaker 2: solutions from industry experts who have developed a knack for
- 0:36Speaker 2: solving problems. A co hosted publication from GRX Marketing and
- 0:40Speaker 2: Finch Marketing, sister companies that are passionate and knowledgeable about
- 0:44Speaker 2: healthcare marketing.
- 0:45Speaker 3: Hey everyone, Nicole McClure, president of Finch Marketing, back for
- 0:49Speaker 3: another episode of Marketing Vitals podcast. I'm here again with
- 0:54Speaker 3: Taylor Chevin, business development specialist on the Finch Marketing team.
- 1:00Speaker 1: Hello, everyone, and today our.
- 1:03Speaker 3: Guest is Jeff Ward, a solotion sales specialist with IQBA
- 1:09Speaker 3: who is our digital marketing partner.
- 1:12Speaker 4: Welcome to the show, Jeff, Welcome. Thank you so much
- 1:15Speaker 4: for inviting me to do this. It's very very excited
- 1:18Speaker 4: and so thank you. Thank you.
- 1:20Speaker 3: Yeah, we're excited to have you here and just dive
- 1:23Speaker 3: a little bit more into IQBA but also email marketing,
- 1:29Speaker 3: digital marketing and all that fun stuff.
- 1:31Speaker 1: So I guess to kick.
- 1:33Speaker 3: It off, give us a little bit of background of
- 1:36Speaker 3: IQBA for those that may not be familiar, what is it,
- 1:40Speaker 3: who do you serve?
- 1:41Speaker 1: That sort of thing.
- 1:43Speaker 4: So I wanted to start out before we talk about
- 1:45Speaker 4: IQBA as the broader subject. I wanted to talk about
- 1:49Speaker 4: where I started from and where I developed this relationship
- 1:54Speaker 4: with IQBA as a pharmacist for thirty one years, and
- 1:59Speaker 4: I'm aging myself there. I spent a lot of time
- 2:02Speaker 4: on the bench, twenty two years on the bench, and
- 2:06Speaker 4: in that time I realize that that that that pharmacy
- 2:11Speaker 4: and pharmacists had a had a greater role in the
- 2:14Speaker 4: in the healthcare system. But but in those twenty two years,
- 2:18Speaker 4: I really wasn't able to develop the impact that I
- 2:23Speaker 4: wanted to. I started out as a as an early
- 2:27Speaker 4: adopter immunizer and and and really that's where all of
- 2:32Speaker 4: the clinical services that pharmacists provided started out, as where
- 2:37Speaker 4: my passion started out. So so with that being said,
- 2:40Speaker 4: the last seven or so I spent in the corporate
- 2:42Speaker 4: world developing learning and development. But but a couple of
- 2:45Speaker 4: years ago i QV approached me and they wanted to
- 2:49Speaker 4: have a pharmacist on board that can that can really
- 2:53Speaker 4: hone in on what they can do to partner with pharmacies.
- 3:00Speaker 4: And with that being said, with my passion being in
- 3:02Speaker 4: all of the things that that that that I've done
- 3:06Speaker 4: in the past, it was just a natural progression for
- 3:09Speaker 4: me to to to to transition into what is now
- 3:15Speaker 4: this just amazing ability, this this digital marketing, this email
- 3:19Speaker 4: marketing for me to get the message out about what
- 3:23Speaker 4: we can do to really grow the profession of pharmacy.
- 3:27Speaker 4: So that's where the passion is. And so IQBA, what
- 3:31Speaker 4: what we do with IQBA And again my my my
- 3:34Speaker 4: partnership lives in representing pharmacies across the United States. We
- 3:38Speaker 4: are a global leader in data data integration, analytics. But
- 3:45Speaker 4: as we know, it's it's it's very very difficult to
- 3:47Speaker 4: take that data and interpret it. So so a lot
- 3:51Speaker 4: of a lot of what I do is taking that
- 3:54Speaker 4: data and then bringing it to life, bringing it to
- 3:57Speaker 4: life in a sense where we can and we can
- 4:01Speaker 4: reach out to healthcare professionals on a very very granular level.
- 4:07Speaker 4: And again I know this was not part of the question,
- 4:09Speaker 4: but but but but what what is really really uh
- 4:14Speaker 4: lagging lacking sometimes in in marketing campaigns is is not
- 4:20Speaker 4: being targeted enough. Right. We we can take an audience
- 4:23Speaker 4: and just and just and just blast it out, but
- 4:27Speaker 4: if you're not targeting that audience correctly, it's it's not
- 4:31Speaker 4: going to get the right message. So so one of
- 4:32Speaker 4: the things that I really really love and I really
- 4:35Speaker 4: enjoy is being able to build an audience, build an
- 4:39Speaker 4: audience of targets for marketing that can really grow the
- 4:43Speaker 4: professional pharmacy. Bringing it back to my my introduction and
- 4:48Speaker 4: and and allowing you to target those audiences for us
- 4:52Speaker 4: to really grow the profession of marketing. And that's where
- 4:55Speaker 4: I get excited. So hopefully we we answered that question
- 4:58Speaker 4: for you, and if there's an extrapolation on that, I
- 5:00Speaker 4: certainly can can go from there.
- 5:04Speaker 5: Yeah, can you, Jeff, can you kind of break down
- 5:08Speaker 5: who you can serve and how you can help them
- 5:12Speaker 5: kind of too.
- 5:13Speaker 4: So a QBA as A as A as a broader
- 5:16Speaker 4: business serves anybody that would be interested in targeting healthcare providers,
- 5:24Speaker 4: So we we we can we can build audiences of
- 5:27Speaker 4: healthcare providers and by the way, also dt C two
- 5:30Speaker 4: direct to consumer. But but where I really enjoy is
- 5:34Speaker 4: is building those audiences of healthcare providers. So we we
- 5:38Speaker 4: represent insurance companies, recruiters. Big Pharma is one of our
- 5:42Speaker 4: biggest clients where we can get that message out and
- 5:46Speaker 4: and again it for me, it goes back to being
- 5:49Speaker 4: able to serve as a pharmacist, being able to take
- 5:53Speaker 4: that message and and and grow. There may be a
- 5:56Speaker 4: drug out there that I may you know, again, and
- 6:00Speaker 4: in my personal opinions don't matter, but I usually deal
- 6:02Speaker 4: with evidence based practice, but there might be a drug
- 6:05Speaker 4: that I may feel more strongly about. And if a
- 6:09Speaker 4: if a company comes to me and says, hey, let's
- 6:11Speaker 4: let's go ahead and and and and try to do
- 6:14Speaker 4: what's called brand conversion or category conversion, it's really a
- 6:19Speaker 4: great experience for me. But but the question was we
- 6:22Speaker 4: represent a whole broad area of insurance companies, financial markets.
- 6:28Speaker 4: We had a we had a client one one time
- 6:30Speaker 4: that was a a financial company that wanted to be
- 6:36Speaker 4: able to market their their loans to physicians h GPS
- 6:41Speaker 4: that had just graduated from from medical school. And so
- 6:46Speaker 4: we we we built an audience and we were able
- 6:48Speaker 4: to target a very specific, very granular audience by by
- 6:54Speaker 4: reaching out, building that audience and being able to do that.
- 6:57Speaker 4: So again it's a very broad audience. We can we
- 7:00Speaker 4: we have you know, customers, clients from all over if
- 7:05Speaker 4: they're looking to target healthcare professionals, you come to the
- 7:10Speaker 4: right place. With IKIVA, we have the the the audience
- 7:13Speaker 4: building capabilities that allow us to target those audiences.
- 7:19Speaker 5: Yeah, and what many people don't know or realize, I
- 7:23Speaker 5: think is i QVA works with first party data. Can
- 7:27Speaker 5: you kind of give an explanation of what that means
- 7:30Speaker 5: and why that's important?
- 7:33Speaker 4: Taylor, That is such a such an excellent question because
- 7:37Speaker 4: one of the one of the exciting things for me
- 7:41Speaker 4: is that I'm able to provide you with audience at
- 7:45Speaker 4: audiences that are first party And what that starts with
- 7:49Speaker 4: is a QBA has a relationship with publishers that is
- 7:52Speaker 4: just amazing. We we have relationships with the largest medical
- 7:59Speaker 4: journals that are out there. And if if again, your
- 8:04Speaker 4: audience should be fairly, fairly knowledgeable about about what happens
- 8:09Speaker 4: when physicians are looking physicians, HCP's, pharmacist, vetnants are looking
- 8:13Speaker 4: for medically relevant information, They're going to reach out to
- 8:18Speaker 4: these publishers and they're going to log in using their credentials. Well,
- 8:26Speaker 4: IQVIA is the I'll say, it's the backbone of that
- 8:30Speaker 4: log in uh situation. It's it's essentially look at it's
- 8:34Speaker 4: a QVIA paper When they when they log in, they
- 8:37Speaker 4: log into an IQBA based opt in type situation, and
- 8:42Speaker 4: what are they providing. They're providing their email address. And
- 8:46Speaker 4: as we know with all of the things that are
- 8:47Speaker 4: going on with the with the web based situations, the
- 8:50Speaker 4: deprecation of third party cookies, all this this this stuff
- 8:53Speaker 4: that's going on that online, that that email identifier is
- 8:57Speaker 4: now the critical the piece that we can utilize to
- 9:03Speaker 4: then target these physicians. So we have an amazing database
- 9:08Speaker 4: ninety five percent of all physicians in the in the country,
- 9:12Speaker 4: a huge database of pharmacists, a huge database of veterinarians
- 9:16Speaker 4: with that often email address. But it doesn't stop at
- 9:19Speaker 4: just that one email address. We have and I throw
- 9:23Speaker 4: this out there four and a half email addresses per HCP.
- 9:28Speaker 4: Where that becomes important is obviously we have that that targeting, right,
- 9:33Speaker 4: we have that targeting, that ability to go after that physician,
- 9:36Speaker 4: but we also have their personal email address, their professional
- 9:38Speaker 4: email address, and maybe at different levels where you know
- 9:44Speaker 4: that we can reach them at times that they're on
- 9:47Speaker 4: their personal email address. So that's that's the first party
- 9:52Speaker 4: nature of it is that we are getting we are
- 9:56Speaker 4: getting the data directly. We're getting that data directly, and
- 9:59Speaker 4: yet you didn't ask the question directly. But where this
- 10:03Speaker 4: becomes really really exciting and where AQBA has really gotten
- 10:06Speaker 4: into a a brand new world and it's it's it's
- 10:09Speaker 4: it's been a few years now is we're now going
- 10:12Speaker 4: to take that email and we're going to target it
- 10:17Speaker 4: using some some some web based pixelation. And so now
- 10:22Speaker 4: the email address has now been identified, so now we
- 10:25Speaker 4: can follow that HCP all over the internet wherever they're
- 10:30Speaker 4: they're doing their research. So if they go on to
- 10:33Speaker 4: a social media platform, for instance, we see them because
- 10:37Speaker 4: they're logged in. And where it becomes really really amazing
- 10:41Speaker 4: is we now can target that particular ah CP. And
- 10:45Speaker 4: when I say target, I like to think of it
- 10:47Speaker 4: more as increasing increasing the visibility of your clients. Whatever
- 10:53Speaker 4: your client is looking to market, we're able to then
- 10:56Speaker 4: target them on a social media platform LinkedIn, Reddit, Facebook,
- 11:03Speaker 4: wherever they are, and we're even able to see them
- 11:06Speaker 4: when they're moving around the internet. Right, So if you
- 11:08Speaker 4: see them on the Internet, we can then throw up
- 11:11Speaker 4: a programmatic ad, a banner ad, a you know whatever
- 11:15Speaker 4: you're looking to target there. So, again getting back to
- 11:19Speaker 4: your question, first party opt in very very valuable because
- 11:24Speaker 4: you're able to really really target and really hone in
- 11:28Speaker 4: on that HGP.
- 11:33Speaker 3: Yeah, thank you for I guess covering that because I mean,
- 11:37Speaker 3: we've talked to some of our clients that haven't been
- 11:41Speaker 3: able to get email aldresses elsewhere, and maybe they're a
- 11:44Speaker 3: little cheaper, but I think a lot of times they
- 11:46Speaker 3: find out that they're not the best option out there
- 11:50Speaker 3: because they're not that first party.
- 11:54Speaker 1: Opted in data.
- 11:55Speaker 3: So I do think it's really we're spending that additional
- 12:00Speaker 3: money just to know you're getting that good email address
- 12:03Speaker 3: for that provider.
- 12:05Speaker 4: Yep. Absolutely, And it's it's just it's it is just
- 12:08Speaker 4: so much more powerful and and by the way, just
- 12:12Speaker 4: on the back end to getting back more into that
- 12:14Speaker 4: that option in email, what what IQBA does in the
- 12:20Speaker 4: interim after we've received those emails is is we also
- 12:24Speaker 4: now on a just an amazing regular cadence, we're sending
- 12:29Speaker 4: out newsletters that number one gives some very very valuable messaging.
- 12:36Speaker 4: Last last week, there was a or it might have
- 12:38Speaker 4: been a couple of weeks ago, medication use in twenty
- 12:41Speaker 4: twenty five, which was just this this amazing white paper
- 12:45Speaker 4: of data aggregation and then interpretation of how medications are
- 12:50Speaker 4: evolving in the United States. Well, that's one way that
- 12:53Speaker 4: we get that message out to to HCPs is we
- 12:56Speaker 4: will send out that newsletter and then when they receive
- 13:00Speaker 4: that newsletter number one, it's information that we're able to provide.
- 13:04Speaker 4: But we're also constantly verifying our database. So if we
- 13:08Speaker 4: get a balance back or or or or even an
- 13:13Speaker 4: opt out, we're going to know that instantaneously to be
- 13:16Speaker 4: able to refresh that that that email database, that opt
- 13:20Speaker 4: in email database. So I apologize, I want to find
- 13:23Speaker 4: a little bit of a tangent there, but thank you.
- 13:26Speaker 1: No, I think it's good information.
- 13:28Speaker 3: And yeah, it's important to know that that data is
- 13:30Speaker 3: constantly refreshed. It's it's not just a stagnet list that
- 13:34Speaker 3: you guys have.
- 13:37Speaker 1: So you touched on it earlier.
- 13:38Speaker 3: Some different strategies of email marketing, social media, how you
- 13:43Speaker 3: can kind of follow the prescriber for their online footprint.
- 13:49Speaker 3: But talk about why you feel it's important to do
- 13:53Speaker 3: different types of marketing for a business.
- 13:58Speaker 4: Yeah, no, absolutely, And I think what you're what you're
- 14:01Speaker 4: referring to is that omni channel approach to to marketing,
- 14:05Speaker 4: which is which is being able to to target somebody
- 14:10Speaker 4: at different levels. So so we we we start with
- 14:14Speaker 4: and again i'll go up the channel. But really what
- 14:17Speaker 4: we're looking at is taking all of these approaches and
- 14:20Speaker 4: and and putting them all together in that omni channel approach.
- 14:23Speaker 4: So we'll start with the email marketing. Uh. There's there's
- 14:27Speaker 4: two different flavors at which we can we can offer
- 14:30Speaker 4: that and that would be a list of emails if
- 14:34Speaker 4: you will, or we can we can deploy an email
- 14:38Speaker 4: deployment on the client's behalf, so you'll you'll you'll take
- 14:42Speaker 4: a message from them, create an HTML which is a
- 14:46Speaker 4: which is a coding type messaging. We'll do the email
- 14:50Speaker 4: deployment for them, will provide messaging for them after the fact.
- 14:55Speaker 4: So that's the two different levels of that. But but
- 14:57Speaker 4: what we're really looking to do is is a tech
- 15:00Speaker 4: these these these messages at an omni channel level, so
- 15:04Speaker 4: that whatever level the what uh, you're not only getting
- 15:07Speaker 4: them out on the email, but you're also getting them
- 15:10Speaker 4: on let's say a banner ad. Right, So so they
- 15:12Speaker 4: see your message at the uh, the email level, and
- 15:17Speaker 4: then they're on the internet later on that day and
- 15:19Speaker 4: they'll see a banner ad or a video ad which
- 15:21Speaker 4: which as we know, video ads are really really uh
- 15:24Speaker 4: something that can make an impact. And and and again
- 15:28Speaker 4: social media we could, we can, we can go on
- 15:30Speaker 4: to different social media platforms different uh again that omni
- 15:35Speaker 4: channel post, so they're seeing it at different levels. And
- 15:39Speaker 4: and and one of the things that you know, it's
- 15:41Speaker 4: back my background is in pharmacy, but I took a
- 15:45Speaker 4: crash course on on marketing. And one of the things
- 15:48Speaker 4: that we realize is in order for a consumer, which
- 15:54Speaker 4: again in this case would be an HCP, but we
- 15:56Speaker 4: can also talk about DTC as we get into this further,
- 15:58Speaker 4: in order for them to to to move them down
- 16:01Speaker 4: that funnel of conversion, right that top level being the
- 16:06Speaker 4: the contemplating the purchase, well quite frankly, education being the
- 16:10Speaker 4: first one. If they're if they're not, if they're not
- 16:12Speaker 4: familiar with the product, and then moving down that level
- 16:16Speaker 4: of conversion, they need to be exposed to a message
- 16:21Speaker 4: many many many times, and and and so and a
- 16:25Speaker 4: and an HCP, a physician, a pharmacist, a veterinarian, they
- 16:30Speaker 4: they need to be exposed to it more times because
- 16:34Speaker 4: of what what what is at stake really is is
- 16:38Speaker 4: the outcome that the clinical outcome of a patient. They
- 16:41Speaker 4: really need to be exposed to a message many many
- 16:45Speaker 4: more times. So when you're talking about h CP messaging,
- 16:49Speaker 4: it's amazingly critical that we are we are reaching them
- 16:53Speaker 4: at all those different levels email, all the way up
- 16:56Speaker 4: to a programmatic banner at or let's say they're listening
- 17:00Speaker 4: to Pandora, right, we can, we can. We can even
- 17:03Speaker 4: throw that messaging out to to iHeart Radio or Pandora
- 17:09Speaker 4: or or even a serious a serious message. Now. It's
- 17:14Speaker 4: interesting too. One of the things that that that was really, uh,
- 17:20Speaker 4: I guess, really quite amazing to me was when when
- 17:25Speaker 4: you are when you're watching television, for instance, and you're
- 17:29Speaker 4: streaming a video and I'm sitting there watching and and
- 17:33Speaker 4: you know, I, I don't have a lot of medical conditions,
- 17:37Speaker 4: but you constantly see those pharmaceutical ads for sky reezy
- 17:41Speaker 4: saoriatic arthritis asthma, right, and and the one thing that
- 17:46Speaker 4: I realized is that the targeting is wrong for me, right,
- 17:50Speaker 4: the targeting is wrong. But what we can do is
- 17:54Speaker 4: we can build an audience. It's it's it's very very
- 17:59Speaker 4: specific to whoever is watching that that particular show, and
- 18:04Speaker 4: then shoot that ad out there based on the targeting,
- 18:08Speaker 4: and again ultimately Like I said, it's all about clinical outcomes.
- 18:11Speaker 4: To me, if the AD is correct and we're getting
- 18:15Speaker 4: that medication into the patient's arms, getting them into their
- 18:18Speaker 4: body so that their clinical outcome is is positive, that's
- 18:22Speaker 4: what I'm looking for. So to me, it's almost like
- 18:27Speaker 4: the marriage of marketing and clinical outcomes. But clinical outcomes
- 18:31Speaker 4: are so critical to me. And hopefully answered your question
- 18:34Speaker 4: on that.
- 18:35Speaker 5: Yeah, I think those are some really good ideas and
- 18:39Speaker 5: very important and something we always kind of tell clients
- 18:43Speaker 5: as you really need to hit them from different angles
- 18:46Speaker 5: and just what the amount of information people are getting nowadays,
- 18:52Speaker 5: it's the messaging has to be so much more.
- 18:55Speaker 4: Yep, very great. Absolutely, Yes.
- 18:58Speaker 5: Can you give us some example of some B two
- 19:01Speaker 5: B digital marketing strategies and how a QBA and Finch
- 19:05Speaker 5: we team up together to help businesses execute those campaigns?
- 19:10Speaker 4: Yeah, No, and and and this is where I really
- 19:12Speaker 4: really get excited. I I've done a couple of really
- 19:16Speaker 4: really exciting campaigns with you and and and and just
- 19:20Speaker 4: you know, talking through some of them. But but but
- 19:23Speaker 4: one of them, one of a really exciting campaign that
- 19:27Speaker 4: that I that brings to mind is is a situation
- 19:32Speaker 4: where we had these long acting antipsychotics. Now, for for
- 19:36Speaker 4: the audience that that may be listening, that that that
- 19:39Speaker 4: may not understand what that is. A long acting antipsychotic
- 19:43Speaker 4: is a medication given to a schizophrenic patient. So somebody
- 19:47Speaker 4: with a mental illness to find as schizophrenia. And one
- 19:51Speaker 4: of the things that becomes really really remarkable in that
- 19:54Speaker 4: disease state is is that they they're oftentimes they they
- 19:59Speaker 4: may not even want to get the medication, but even
- 20:03Speaker 4: if they want to get the medication, it's all about access, right,
- 20:06Speaker 4: and so what what do you have to do to
- 20:08Speaker 4: be able to get this medication? And it has to
- 20:11Speaker 4: be injected generally, you know, at least every thirty days,
- 20:16Speaker 4: and it has to be done in a healthcare setting. Well,
- 20:20Speaker 4: over the last it's been at least ten years, pharmacists
- 20:24Speaker 4: have been able to inject these long acting antipsychotics. But again,
- 20:30Speaker 4: one of the one of the aspects that we we
- 20:33Speaker 4: we we realize is that HCPs did not realize that
- 20:38Speaker 4: pharmacists can do this, and so we needed to get
- 20:42Speaker 4: the message out. And by the way, these these these
- 20:45Speaker 4: critically these very brittle schizophrenic patients a lot of times
- 20:51Speaker 4: aren't going to go into the doctor's office. So so
- 20:53Speaker 4: the so the HCP realizes really quickly that if we
- 20:57Speaker 4: can get this medication into them, they're going to be
- 21:00Speaker 4: obviously get into a better situation. So we have these
- 21:03Speaker 4: pharmacists that can go ahead and inject the medication, physicians HCPs,
- 21:09Speaker 4: psychiatrists nps pas that didn't quite have the message that
- 21:15Speaker 4: pharmacists can do this. So we develop a campaign that
- 21:20Speaker 4: is going to what's called geo target a stores where
- 21:26Speaker 4: pharmacists are allowed to go ahead and inject these medications. Now,
- 21:32Speaker 4: this was done really really amazingly in only ten stores
- 21:36Speaker 4: in a very specific location. So the campaign was designed
- 21:40Speaker 4: to target these long acting antipsychotics, and we then targeted
- 21:48Speaker 4: HGPS right psychiatrists in general that were within a ten
- 21:52Speaker 4: mile radius of each of z stores. And that the
- 21:57Speaker 4: campaign went out and then after the fact, one of
- 22:01Speaker 4: the key components of all of this is able to
- 22:05Speaker 4: come up over the top and then measure script left right,
- 22:09Speaker 4: measure the increase in prescriptions or injections that had happened
- 22:14Speaker 4: after the fact. So it was a really cool situation
- 22:17Speaker 4: where you do the campaign and then you're able to
- 22:20Speaker 4: measure it after the fact. To show the impact. And
- 22:23Speaker 4: again I go back to this and I apologize clinical outcomes.
- 22:27Speaker 4: Right when I see an antipsychotic going into a patient,
- 22:32Speaker 4: I'm showing that this patient is now going to become better.
- 22:35Speaker 4: And that's where it becomes exciting to me. So hopefully
- 22:38Speaker 4: explain that I did have another example of a DTC campaign.
- 22:42Speaker 4: But again you you you were, you were more interested
- 22:45Speaker 4: in the B two B but but it's just that's
- 22:47Speaker 4: just a perfect example of the impact that that that
- 22:52Speaker 4: geo targeting and granular targeting with these audiences can really
- 22:56Speaker 4: produce for for your clients.
- 23:00Speaker 1: For sure.
- 23:00Speaker 3: And I know again on the Finch side, we've done
- 23:03Speaker 3: some other things such as reaching out to hospital providers
- 23:07Speaker 3: to do an email campaign for a client, some website retargeting.
- 23:12Speaker 1: So there's definitely a lot of options.
- 23:14Speaker 3: Out there for the B two B side for Finch clients.
- 23:19Speaker 3: So what advice would you give a company that's trying
- 23:25Speaker 3: to break out into a new industry. So say there's
- 23:29Speaker 3: you know, somebody that's trying to break into pharmacy for example,
- 23:33Speaker 3: again not trying to market to patients, but trying to
- 23:37Speaker 3: market to either pharmacy owners or other businesses within the
- 23:41Speaker 3: healthcare industry.
- 23:42Speaker 4: One of the things that I get approached all of
- 23:46Speaker 4: the time is with pharmacy automation. Right, These these companies
- 23:52Speaker 4: that offer robotics for instance, Yeah, and they are looking
- 23:56Speaker 4: to build an audience to be able to target to
- 24:00Speaker 4: pharmacies nationwide and and there. And so so what we
- 24:05Speaker 4: do is we will go ahead on the same level
- 24:08Speaker 4: of the conversations that we had before. We will We're
- 24:12Speaker 4: gonna build. We're going to build an audience of pharmacists,
- 24:16Speaker 4: pharmacists in charge, decision makers within the pharmacy that we
- 24:20Speaker 4: can then target. And again I've dealt with for instance,
- 24:25Speaker 4: there's a product that is a pill counter for instance,
- 24:28Speaker 4: this particular company just is absolutely looking to to have
- 24:33Speaker 4: it brought out into other pharmacies and and so so
- 24:37Speaker 4: they came to to to to want an audience that
- 24:41Speaker 4: that that that we can now build and and and
- 24:44Speaker 4: then target them at all of those levels that we've
- 24:47Speaker 4: discussed before. Email marketing, right, email is typically the first
- 24:51Speaker 4: start and then and then go all the way up
- 24:53Speaker 4: that chain too, uh, to social media marketing as well.
- 24:57Speaker 4: And so so that's that's key and typically one I
- 25:00Speaker 4: get when I get requests like that, it's all about
- 25:06Speaker 4: breaking into some kind of automation, some kind of counting, uh,
- 25:13Speaker 4: maybe an app, an app they may want to advertise
- 25:18Speaker 4: to get out, and you could do that with any
- 25:20Speaker 4: particular product. But the key here is is is the
- 25:23Speaker 4: audience that we have is very very robust. We we
- 25:28Speaker 4: we can we can provide you with administrators. Now, one
- 25:32Speaker 4: key that I really want to differentiate though, when we're
- 25:34Speaker 4: talking about like decision makers, if the the decision maker
- 25:39Speaker 4: is not an HCP, then we're not going to be
- 25:44Speaker 4: dealing with first party emails. It's going to be generally
- 25:48Speaker 4: emails that we've gotten from other sources. So just we
- 25:51Speaker 4: want to differentiate when we talk about eh GPS. But
- 25:54Speaker 4: the whole question arises about how we're able to whatever
- 25:58Speaker 4: your product is. And again, apps, automation, robotics, anything like that.
- 26:07Speaker 4: There's even a company out there who does a flavoring
- 26:11Speaker 4: for prescription medications. Again, they're looking for audio for a
- 26:17Speaker 4: target audience of pharmacist, pharmacy managers, any of the decision
- 26:23Speaker 4: maker you typically pharmacy owners that can make a decision.
- 26:26Speaker 4: And hopefully that answered a question for you.
- 26:29Speaker 1: Yep, No, that's perfect example.
- 26:31Speaker 5: Okay, all right, just to kind of wrap things up
- 26:34Speaker 5: a little bit. Are there keeping in mind, you know,
- 26:38Speaker 5: those types of clients that are really trying to either
- 26:42Speaker 5: break into a new industry or more of the B
- 26:46Speaker 5: two B side, like really targeting either pharmacy owners, hospital systems,
- 26:52Speaker 5: decision makers in the healthcare world. Are there any newer
- 26:56Speaker 5: services that we haven't really touched base on in this
- 26:59Speaker 5: podcast that IQBA offers that you would like to highlight.
- 27:03Speaker 4: Well, I think the biggest one that we we we
- 27:05Speaker 4: really didn't touch upon and and and you guys utilize
- 27:09Speaker 4: this a lot, is that there's that IYEMOS system, the
- 27:13Speaker 4: the IQBA Media operating system, and this is where where
- 27:18Speaker 4: if if, if, if a client is is you can
- 27:21Speaker 4: you can get in there and really build the audiences
- 27:24Speaker 4: and look at that activation yourself, like look at a
- 27:27Speaker 4: campaign and how it's it's running yourself. And that that
- 27:30Speaker 4: seems to be the biggest aspect of it. But but
- 27:34Speaker 4: IQBA as a as a whole has has many many
- 27:39Speaker 4: divisions that can help clients. For instance, I had a
- 27:44Speaker 4: request last week for for claims data. So so one
- 27:47Speaker 4: of the things that we we can offer clients is
- 27:51Speaker 4: if you are we have we have ninety plus percentage
- 27:55Speaker 4: of all pharmacy claims in the United States. We have
- 27:58Speaker 4: ninety plus medical claims in the United States. So if
- 28:01Speaker 4: they're looking for analytics of let's say they're looking to
- 28:06Speaker 4: to target a an HCP that prescribes and again we'll
- 28:11Speaker 4: go back to sky Reezy, Right, that's an area where
- 28:15Speaker 4: we can provide an audience that is very, very valuable
- 28:24Speaker 4: because now we're able to say doctor Jones in Midland,
- 28:29Speaker 4: Texas is the top prescriber of sky Reezy in the country. Right,
- 28:34Speaker 4: And so that's an area that we didn't target, but
- 28:36Speaker 4: we also have many, many other services that that could
- 28:39Speaker 4: be of use. The biggest thing to keep in mind
- 28:43Speaker 4: is ultimately i QB is a data aggregation and and
- 28:48Speaker 4: and again we started out this by saying that I
- 28:52Speaker 4: love to take all of this data, all of these
- 28:55Speaker 4: insights and help you to to to and help you
- 29:01Speaker 4: and your clients design campaigns based on those insights, whatever
- 29:06Speaker 4: those may be, vaccine deficits, specialty drug deficits, things like that.
- 29:13Speaker 4: And so that's the bigger The bigger picture when you
- 29:16Speaker 4: come up to a ten thousand foot altitude is data
- 29:20Speaker 4: aggregation and then taking those all of that data and
- 29:25Speaker 4: making it into a story, right, make it into a
- 29:27Speaker 4: story that's going to help your clients quite frankly make money.
- 29:34Speaker 4: In my case, my passion comes from helping patients. But
- 29:37Speaker 4: you know, ultimately companies want to be successful, so it's
- 29:39Speaker 4: taking that data and helping them be way more successful
- 29:43Speaker 4: than they possibly ever could without without without the data,
- 29:48Speaker 4: right without you know, the seat of the pants marketing,
- 29:51Speaker 4: the seat of the pants, is this what we should
- 29:54Speaker 4: do that doesn't work? We want to provide those insights
- 29:58Speaker 4: for your clients to help them be better than they
- 30:02Speaker 4: ever could be.
- 30:04Speaker 3: Yeah, and I know data is good and that's well
- 30:07Speaker 3: with a lot of businesses, pharmacy owners, that sort of thing.
- 30:11Speaker 3: So thank you for joining us today and providing insights
- 30:16Speaker 3: of digital marketing and how iqvia can help.
- 30:20Speaker 1: We appreciate you joining us.
- 30:22Speaker 4: No, thank you so much. And you guys are amazing,
- 30:25Speaker 4: just an amazing group. Taylor in yourself and then and
- 30:29Speaker 4: then the group uh of people that work with you,
- 30:32Speaker 4: just amazing. You guys do just a fabulous, fabulous job
- 30:35Speaker 4: taking care of the of the clients and making sure
- 30:38Speaker 4: that they're taken care of in the best way possible.
- 30:40Speaker 4: And it's so appreciated and and heartwarming when you see
- 30:45Speaker 4: a successful outcomes and and and when I say outcomes,
- 30:48Speaker 4: both on the patient level and the business level. So
- 30:51Speaker 4: thank you so much, very much appreciated, Oh.
- 30:54Speaker 1: I appreciate that.
- 30:56Speaker 3: For more information on IQVA services and how we to
- 31:00Speaker 3: help you with digital marketing, be sure to check out
- 31:02Speaker 3: our website finchmarketingsolutions dot com. Thank you for joining us
- 31:07Speaker 3: for another episode of Marketing Finals podcast.
- 31:11Speaker 4: Thank you so much,